In summary, these findings strongly support a role for the CDKN2A-CDK4-E2F3 axis in regulation of skeletal muscle fiber–type proportion and function, and, thus, they are of clinical significance to muscle disorders and chronic diseases, like insulin resistance and diabetes, that involve muscle dysfunction. This evidence concerns the gene E2F3 and diabetes mellitus.